Silent myocardial ischemia is known to occur in the general medical intensive care unit population immediately following tracheal extubation. We believe these patients are at risk for primary cardiac events in the 4 hours immediately following extubation. Metoprolol is a selective beta-1 antagonist, with little to no beta-2 activity at low and moderate doses. The cardioprotective effects of beta blockade have been well documented in randomized controlled trials. In patients undergoing extubation, prophylactic use of intravenous metoprolol may reduce post-extubation ischemia events as well as precursors of cardiogenic pulmonary edema (atrial and ventricular wall tension). Our primary hypothesis is that prophylactic metoprolol (titrated to reduce resting heart rate by at least 10%) prior to tracheal extubation will reduce the rate of ischemia as judged by ST segment analysis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Metoprolol administered intravenously in 2.5mg boluses until the resting heart rate falls by 10% from baseline to a maximum dose of 10mg, or until there is any apparent adverse reaction.
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
The rate of ischemia as judged by ST segment analysis in the 4h following extubation
Time frame: 4 hours
Rate-pressure product following extubation
Time frame: 30min, 2h, 4h
Troponin T elevations, the incidence of cardiogenic edema, and the rate of reintubation
Time frame: 48h
Pro-BNP levels
Time frame: 30min
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.